Andy Plump, architect of Takeda’s R&D overhaul, to retire next year
Plump joined Takeda during a turbulent period, pushed the company to work more closely with young biotechs and will leave it with what CEO Julie Kim called a “lasting foundation.”
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.